US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist

49.860
+1.930+4.03%

Close Apr 26 16:00 ET

49.860
0.0000.00%

Post 16:01 ET

6.05BMarket Cap-11204P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-15.76%-594.74M

30.46%-97.88M

-9.50%-169.09M

-40.30%-150.16M

-59.21%-177.62M

8.77%-513.75M

-25.11%-140.74M

8.43%-154.42M

16.83%-107.02M

27.23%-111.56M

Net income from continuing operations

18.94%-528.63M

46.64%-88.58M

26.68%-140.24M

21.76%-122.04M

-27.96%-177.78M

12.62%-652.17M

-12.21%-165.99M

2.20%-191.27M

28.84%-155.98M

24.35%-138.94M

Operating gains losses

-99.64%120K

---32K

--133K

--0

--19K

-83.41%32.89M

--0

----

Depreciation and amortization

14.59%1.7M

14.49%490K

13.45%405K

19.88%410K

10.83%399K

-0.34%1.49M

13.83%428K

30.29%357K

-23.66%342K

-8.63%360K

Other non cash items

-8.27%26.29M

31.63%6.58M

-23.37%6.49M

-8.60%6.52M

-16.85%6.71M

353.03%28.66M

274.46%5M

220.11%8.47M

2,135.74%7.13M

297.68%8.07M

Change In working capital

-1,175.12%-200.17M

-862.59%-42.56M

-102.44%-57.5M

-439.46%-64.33M

-1,863.19%-35.79M

83.21%-15.7M

89.16%-4.42M

51.44%-28.4M

-62.72%18.95M

95.96%-1.82M

-Change in receivables

-8,466.95%-198.72M

-10,284.38%-37.17M

-10,066.55%-58.36M

-6,578.55%-79.41M

-730.21%-23.78M

123.51%2.38M

104.88%365K

69.77%-574K

-65.37%-1.19M

--3.77M

-Change in inventory

12.61%-60.65M

-84.18%-47.82M

141.33%4.67M

-13.11%-17.65M

100.87%144K

-325.30%-69.4M

-77.33%-25.96M

-650.24%-11.3M

-318.15%-15.6M

---16.53M

-Change in prepaid assets

83.71%-1.87M

197.06%5.81M

-15.02%-10.22M

-13.55%2.64M

-132.04%-107K

14.89%-11.48M

21.48%-5.99M

-651.33%-8.88M

284.76%3.06M

105.74%334K

-Change in payables and accrued expense

183.75%35.12M

-17.35%31.47M

194.80%10.43M

288.20%22.54M

-978.52%-29.33M

12,928.42%12.38M

-16.13%38.08M

82.95%-11.01M

-118.09%-11.98M

94.21%-2.72M

-Change in other current assets

-48.55%25.94M

147.19%5.15M

-219.97%-4.03M

-83.10%7.55M

29.69%17.28M

193.89%50.43M

80.66%-10.92M

-21.39%3.36M

582.45%44.66M

72.92%13.32M

Cash from discontinued investing activities

Operating cash flow

-15.76%-594.74M

30.46%-97.88M

-9.50%-169.09M

-40.30%-150.16M

-59.21%-177.62M

8.77%-513.75M

-25.11%-140.74M

8.43%-154.42M

16.83%-107.02M

27.23%-111.56M

Investing cash flow

Cash flow from continuing investing activities

-101.13%-674K

-100.00%4K

-100.04%-47K

-100.45%-372K

99.90%-259K

-75.81%59.89M

46.07%124.13M

-30.54%124.78M

-36.09%82.93M

-85.30%-271.95M

Net PPE purchase and sale

55.77%-674K

100.47%4K

76.02%-47K

4.86%-372K

-201.16%-259K

-38.17%-1.52M

-4,378.95%-851K

44.32%-196K

-57.66%-391K

82.23%-86K

Net investment purchase and sale

--0

-75.31%61.42M

47.04%124.98M

-30.57%124.98M

-35.91%83.32M

-85.85%-271.86M

Cash from discontinued investing activities

Investing cash flow

-101.13%-674K

-100.00%4K

-100.04%-47K

-100.45%-372K

99.90%-259K

-75.81%59.89M

46.07%124.13M

-30.54%124.78M

-36.09%82.93M

-85.30%-271.95M

Financing cash flow

Cash flow from continuing financing activities

7.89%394.5M

75.46%-3.91M

-40.37%5.75M

132.95%1.56M

3.82%391.11M

-6.78%365.66M

-104.15%-15.95M

354.53%9.64M

-204.62%-4.74M

22,982.35%376.7M

Net common stock issuance

1.12%384.39M

--0

1.12%384.39M

-0.06%380.12M

--0

--380.12M

Proceeds from stock option exercised by employees

198.01%76.65M

616.45%27.09M

-45.89%5.76M

257.32%26.09M

342.95%17.72M

45.64%25.72M

-1.33%3.78M

328.82%10.64M

-16.66%7.3M

54.56%4M

Net other financing activities

-65.60%-66.54M

-57.16%-31M

98.90%-11K

-103.79%-24.53M

-48.31%-11M

-594.23%-40.18M

-8,223.63%-19.73M

-177.84%-1M

-184.27%-12.04M

-675.73%-7.42M

Cash from discontinued financing activities

Financing cash flow

7.89%394.5M

75.46%-3.91M

-40.37%5.75M

132.95%1.56M

3.82%391.11M

-6.78%365.66M

-104.15%-15.95M

354.53%9.64M

-204.62%-4.74M

22,982.35%376.7M

Net cash flow

Beginning cash position

-13.82%553.07M

-22.54%453.5M

1.91%617.34M

20.68%766.36M

-13.82%553.08M

13.18%641.76M

105.20%585.45M

122.43%605.76M

137.84%635.01M

13.18%641.76M

Current changes in cash

-127.81%-200.91M

-212.59%-101.78M

-717.05%-163.39M

-416.71%-148.97M

3,233.39%213.23M

-214.95%-88.19M

-109.14%-32.56M

-252.14%-20M

-615.74%-28.83M

97.72%-6.81M

Effect of exchange rate changes

127.66%135K

212.30%584K

-47.74%-458K

89.04%-47K

-12.50%56K

75.79%-488K

2,237.50%187K

-80.23%-310K

-78.01%-429K

103.97%64K

End cash Position

-36.30%352.3M

-22.54%453.5M

1.91%617.34M

20.68%766.36M

-13.82%553.07M

105.20%585.45M

122.43%605.76M

137.84%635.01M

Free cash flow

-15.57%-595.51M

30.81%-97.97M

-9.39%-169.13M

-40.14%-150.53M

-59.32%-177.88M

8.68%-515.27M

-25.84%-141.6M

8.50%-154.61M

16.69%-107.42M

27.41%-111.65M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-15.76%-594.74M	30.46%-97.88M	-9.50%-169.09M	-40.30%-150.16M	-59.21%-177.62M	8.77%-513.75M	-25.11%-140.74M	8.43%-154.42M	16.83%-107.02M	27.23%-111.56M
Net income from continuing operations	18.94%-528.63M	46.64%-88.58M	26.68%-140.24M	21.76%-122.04M	-27.96%-177.78M	12.62%-652.17M	-12.21%-165.99M	2.20%-191.27M	28.84%-155.98M	24.35%-138.94M
Operating gains losses	-99.64%120K	---32K	--133K	--0	--19K	-83.41%32.89M	--0	----	----	----
Depreciation and amortization	14.59%1.7M	14.49%490K	13.45%405K	19.88%410K	10.83%399K	-0.34%1.49M	13.83%428K	30.29%357K	-23.66%342K	-8.63%360K
Other non cash items	-8.27%26.29M	31.63%6.58M	-23.37%6.49M	-8.60%6.52M	-16.85%6.71M	353.03%28.66M	274.46%5M	220.11%8.47M	2,135.74%7.13M	297.68%8.07M
Change In working capital	-1,175.12%-200.17M	-862.59%-42.56M	-102.44%-57.5M	-439.46%-64.33M	-1,863.19%-35.79M	83.21%-15.7M	89.16%-4.42M	51.44%-28.4M	-62.72%18.95M	95.96%-1.82M
-Change in receivables	-8,466.95%-198.72M	-10,284.38%-37.17M	-10,066.55%-58.36M	-6,578.55%-79.41M	-730.21%-23.78M	123.51%2.38M	104.88%365K	69.77%-574K	-65.37%-1.19M	--3.77M
-Change in inventory	12.61%-60.65M	-84.18%-47.82M	141.33%4.67M	-13.11%-17.65M	100.87%144K	-325.30%-69.4M	-77.33%-25.96M	-650.24%-11.3M	-318.15%-15.6M	---16.53M
-Change in prepaid assets	83.71%-1.87M	197.06%5.81M	-15.02%-10.22M	-13.55%2.64M	-132.04%-107K	14.89%-11.48M	21.48%-5.99M	-651.33%-8.88M	284.76%3.06M	105.74%334K
-Change in payables and accrued expense	183.75%35.12M	-17.35%31.47M	194.80%10.43M	288.20%22.54M	-978.52%-29.33M	12,928.42%12.38M	-16.13%38.08M	82.95%-11.01M	-118.09%-11.98M	94.21%-2.72M
-Change in other current assets	-48.55%25.94M	147.19%5.15M	-219.97%-4.03M	-83.10%7.55M	29.69%17.28M	193.89%50.43M	80.66%-10.92M	-21.39%3.36M	582.45%44.66M	72.92%13.32M
Cash from discontinued investing activities
Operating cash flow	-15.76%-594.74M	30.46%-97.88M	-9.50%-169.09M	-40.30%-150.16M	-59.21%-177.62M	8.77%-513.75M	-25.11%-140.74M	8.43%-154.42M	16.83%-107.02M	27.23%-111.56M
Investing cash flow
Cash flow from continuing investing activities	-101.13%-674K	-100.00%4K	-100.04%-47K	-100.45%-372K	99.90%-259K	-75.81%59.89M	46.07%124.13M	-30.54%124.78M	-36.09%82.93M	-85.30%-271.95M
Net PPE purchase and sale	55.77%-674K	100.47%4K	76.02%-47K	4.86%-372K	-201.16%-259K	-38.17%-1.52M	-4,378.95%-851K	44.32%-196K	-57.66%-391K	82.23%-86K
Net investment purchase and sale	--0	--0	--0	--0	--0	-75.31%61.42M	47.04%124.98M	-30.57%124.98M	-35.91%83.32M	-85.85%-271.86M
Cash from discontinued investing activities
Investing cash flow	-101.13%-674K	-100.00%4K	-100.04%-47K	-100.45%-372K	99.90%-259K	-75.81%59.89M	46.07%124.13M	-30.54%124.78M	-36.09%82.93M	-85.30%-271.95M
Financing cash flow
Cash flow from continuing financing activities	7.89%394.5M	75.46%-3.91M	-40.37%5.75M	132.95%1.56M	3.82%391.11M	-6.78%365.66M	-104.15%-15.95M	354.53%9.64M	-204.62%-4.74M	22,982.35%376.7M
Net common stock issuance	1.12%384.39M	--0	--0	--0	1.12%384.39M	-0.06%380.12M	--0	--0	--0	--380.12M
Proceeds from stock option exercised by employees	198.01%76.65M	616.45%27.09M	-45.89%5.76M	257.32%26.09M	342.95%17.72M	45.64%25.72M	-1.33%3.78M	328.82%10.64M	-16.66%7.3M	54.56%4M
Net other financing activities	-65.60%-66.54M	-57.16%-31M	98.90%-11K	-103.79%-24.53M	-48.31%-11M	-594.23%-40.18M	-8,223.63%-19.73M	-177.84%-1M	-184.27%-12.04M	-675.73%-7.42M
Cash from discontinued financing activities
Financing cash flow	7.89%394.5M	75.46%-3.91M	-40.37%5.75M	132.95%1.56M	3.82%391.11M	-6.78%365.66M	-104.15%-15.95M	354.53%9.64M	-204.62%-4.74M	22,982.35%376.7M
Net cash flow
Beginning cash position	-13.82%553.07M	-22.54%453.5M	1.91%617.34M	20.68%766.36M	-13.82%553.08M	13.18%641.76M	105.20%585.45M	122.43%605.76M	137.84%635.01M	13.18%641.76M
Current changes in cash	-127.81%-200.91M	-212.59%-101.78M	-717.05%-163.39M	-416.71%-148.97M	3,233.39%213.23M	-214.95%-88.19M	-109.14%-32.56M	-252.14%-20M	-615.74%-28.83M	97.72%-6.81M
Effect of exchange rate changes	127.66%135K	212.30%584K	-47.74%-458K	89.04%-47K	-12.50%56K	75.79%-488K	2,237.50%187K	-80.23%-310K	-78.01%-429K	103.97%64K
End cash Position	-36.30%352.3M	-36.30%352.3M	-22.54%453.5M	1.91%617.34M	20.68%766.36M	-13.82%553.07M	-13.82%553.07M	105.20%585.45M	122.43%605.76M	137.84%635.01M
Free cash flow	-15.57%-595.51M	30.81%-97.97M	-9.39%-169.13M	-40.14%-150.53M	-59.32%-177.88M	8.68%-515.27M	-25.84%-141.6M	8.50%-154.61M	16.69%-107.42M	27.41%-111.65M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall